Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis-Reference-Cited by-同舟云学术

Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis

Published:2016-06 Issue:6 Volume:99 Page:1153-1164
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Whibley Natasha,Tritto Elaine,Traggiai Elisabetta,Kolbinger Frank,Moulin Pierre,Brees Dominique,Coleman Bianca M.,Mamo Anna J.,Garg Abhishek V.,Jaycox Jillian R.,Siebenlist Ulrich,Kammüller Michael,Gaffen Sarah L.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.4A0915-428R/fullpdf

Reference74 articles.

1. Effect of IL-17A blockade with secukinumab in autoimmune diseases;Patel;Ann. Rheum. Dis.,2013

2. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis;Leonardi;N. Engl. J. Med.,2012

3. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis;Papp;N. Engl. J. Med.,2012

4. Secukinumab in plaque psoriasis-results of two phase 3 trials;ERASURE Study Group; FIXTURE Study Group;N. Engl. J. Med.,2014

5. Secukinumab: first global approval;Sanford;Drugs,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single‐center retrospective study;The Journal of Dermatology;2024-03-14

2. The IL-17 pathway as a target in giant cell arteritis;Frontiers in Immunology;2024-01-17

3. The IL-17 family in diseases: from bench to bedside;Signal Transduction and Targeted Therapy;2023-10-11

4. IκBζ is an essential mediator of immunity to oropharyngeal candidiasis;Cell Host & Microbe;2023-10

5. Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis;Medical Mycology;2023-08